Brief: Cleo Diagnostics Raises A$5M
18/12/2025 01:13
Dec 18 (Reuters) - Cleo Diagnostics Ltd COV.AX: RAISES A$5M AT A$0.60 PER SHARE Further company coverage: COV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CLEO Diagnostics
See all newsAustralia's Cleo Diagnostics jumps after cancer screening test meets milestone
Brief: Cleo Diagnostics Files Patents For Its Ovarian Cancer Screening Test
Australia's Cleo Diagnostics jumps as ovarian cancer test hits validation milestone
Brief: Cleo Diagnostics Receives First Batch Of Commercially Manufactured Test Kits
Brief: Cleo Diagnostics Raises A$5M